Skip to main content
Translational Oncology logoLink to Translational Oncology
. 2017 Aug 29;10(5):828–830. doi: 10.1016/j.tranon.2017.08.001

Proving of a Mathematical Model of Cell Calculation Based on Apparent Diffusion Coefficient

Alexey Surov 1,, Nikita Garnov 1
PMCID: PMC5577394  PMID: 28863287

Abstract

OBJECTIVES: Recently, Atuegwu et al. proposed a mathematical model based on ADCmean and ADCmin to calculation of cellularity. Our purpose was to compare the calculated cellularity according to the formula with the estimated cell count by histopathology in different tumors. METHODS: For this study, we re-analyzed our previous data regarding associations between ADC parameters and histopathological findings. Overall, 134 patients with different tumors were acquired for the analysis. For all tumors, the number of tumor cells was calculated according to Atuegwu et al. 2013. We performed a correlation analysis between the calculated and estimated cellularity. Thereby, Pearson's correlation coefficient was used and P < .05 was taken to indicate statistical significance in all instances. RESULTS: The estimated and calculated cellularity correlated well together in HNSCC (r = 0.701, P = .016) and lymphomas (r = 0.661, P = .001), and moderately in rectal cancer (r = 0.510, P = .036). There were no statistically significant correlations between the estimated and calculated cellularity in uterine cervical cancer, meningiomas, and in thyroid cancer. CONCLUSION: The proposed formula for cellularity calculation does not apply for all tumors. It may be used for HNSCC, cerebral lymphomas and rectal cancer, but not for uterine cervical cancer, meningioma, and thyroid cancer. Furthermore, its usefulness should be proved for other tumors.

Introduction

Magnetic resonance imaging (MRI) is used as a staging investigation in numerous malignant diseases. Some MRI techniques, for instance, diffusion weighted imaging (DWI), are influenced by histological composition of investigated tissue, and, therefore, can be used as marker of tissue architecture [1], [2], [3], [4]. DWI measures the random motion of water molecules in tissues [1], [2]. The water diffusion can be quantified by a parameter, defined as the apparent diffusion coefficient (ADC) [1], [2], [3], [4]. ADC reflects the mobility of water within tissues and documents quantitatively restriction of water diffusion by several barriers, such as cell membranes [1], [2], [3], [4]. Therefore, ADC can indirectly provide information about cell density [1].

Previously, numerous experimental and clinical studies reported data regarding associations between DWI and histopathological features in different tumors and tumor like lesions [3], [4], [5], [6], [7]. In most publications, different ADC fractions, especially minimum ADC (ADCmin) and mean ADC (ADCmean) showed statistically significant inverse correlations with cell count in several tumors [5], [6], [7].

Recently, Atuegwu et al. proposed a mathematical model based on ADCmean and ADCmin to calculation of cellularity [8]. The authors observed a strong and significant Pearson correlation and a strong concordance correlation between the estimated and the simulated number of tumor cells [8]. However, the proposed formula was not proven by histopathological examination, and, therefore, it is unclear, if the mathematical model provides real cell count or not.

Therefore, our purpose was to compare the calculated cellularity according to the formula with the estimated cell count by histopathology in different tumors.

Materials and Methods

Estimated Cellularity

For this study, we re-analyzed our previous data regarding associations between ADC parameters and histopathological findings [9], [10], [11], [12], [13], [14]. Overall, 134 patients with different tumors were acquired for the analysis (Table 1). In all cases, the diagnosis was confirmed by histopathological examination. For every tumor entity, cellularity was estimated as an average cell count per 2–5 high power fields (×400; 0.16 mm2 per field). All images were analyzed by using a research microscope Jenalumar, with camera Diagnostic instruments 4.2 as reported previously [6], [9].

Table 1.

Primary Tumors, Number of Patients, and MRI Technique

Entity n Magnetic Field b values
Uterine cervical cancer 21 3 T b0 and b1000
HNSCC 3 T b0 and b800
Cerebral lymphoma 21 1.5 T b0 and b1000
Meningioma 49 1.5 T b0 and b1000
Rectal cancer 17 3 T b0 and b1000
Thyroid cancer 15 3 T b0 and b800

HNSCC, head neck squamous cell carcinoma.

Furthermore, in all cases the tumors were investigated by DWI. Thereby, different equipment and b values were used (Table 1).

Cell Number Calculation

For all tumors, the number of tumor cells was calculated according to Atuegwu et al. 2013 [8]. In this study, ADC values were converted to tumor cell number N using following equation:

N=θADCwADCmeanADCwADCmin (8)

Where ADCw is the ADC of free water (ADCw = 3 × 10−3 mm2/s); ADCmin is the minimum and ADCmean the mean ADC value within the ROI, respectively. θ is the carrying capacity which can be interpreted as the maximum number of cells that can be contained within a given volume [15]. Due to varied imaging voxel sizes for different entities, we converted the given volumes to a standard volume of 1 mm3. To calculate θ, we used the tumor cell volume of 4189 μm3 [8].

Statistical Analysis

Because the fact that the formula calculated cells in a volume and previously reported data were based on cell count on high power fields, we performed a correlation analysis between the calculated and estimated cellularity. Thereby Pearson's correlation coefficient was used and P < .05 was taken to indicate statistical significance in all instances.

Results

Table 1 shows the results of the performed correlation analysis between the calculated and estimated cellularity. In the total sample, the calculated cellularity did not correlated with the estimated cell count. The subgroup analysis showed the following. Both parameters correlated well in HNSCC and lymphomas, and moderately in rectal cancer (Table 2). There were no statistically significant correlations between the estimated and calculated cellularity in uterine cervical cancer, meningiomas, and in thyroid cancer.

Table 2.

Correlations Between the Estimated and Calculated Cellularity

Entity n Correlation Coefficients
Uterine cervical cancer 21 r = −0.245,
P = .285
HNSCC 11 r = 0.701
P = .016
Cerebral lymphoma 21 r = 0.661
P = .001
Meningioma 49 r = −0.110
P = .450
Rectal cancer 17 = 0.510
P = .036
Thyroid cancer 15 r = 0.350
P = .202
Total 134 r = 0.119
P = .190

HNSCC, head neck squamous cell carcinoma.

Significant correlations are highlighted in bold.

Discussion

Our study provides data about calculated and estimated cellularity in different tumors.

As seen, the estimated and calculated cellularity correlated statistically significant in HNSCC, lymphoma and rectal cancer. Therefore, the proposed formula for cellularity calculation [8] can be used in clinical practice for these entities. However, there were no significant correlations between the estimated cell count and calculated cellularity in uterine cervical cancer, meningioma, and thyroid cancer.

It is unclear, why the formula reflects the real cell count in some tumors, whereas in other does not. Several causes of this phenomenon are possible. The formula is based on ADC values, namely ADCmean and ADCmin and assumes that the ADC fractions correlate with cell count [8]. Recently, two meta-analyses regarding associations between ADCmean and ADCmin and cellularity were published [16], [17]. These articles identified the following: firstly, ADCmin did not better correlate with cellularity in comparison to ADCmean [17]. Secondly, different tumors showed also different associations between ADC and cell count [16]. In detail, it has been shown that correlation between ADC and cellularity ranged in different tumors [16]. Overall, the identified correlation coefficients for the analyzed tumors were as follows: glioma (ρ = −0.66), ovarian cancer (ρ = −0.64), lung cancer, (ρ = −0.63), uterine cervical cancer (ρ = −0.57), prostatic cancer (ρ = −0.56), renal cell carcinoma (ρ = −0.53), squamous cell carcinoma of head and neck (ρ = −0.53), breast cancer (ρ = −0.48), meningioma (ρ = −0.45), and lymphoma (ρ = −0.25) [16].

Another cause of our controversial results is the fact that not only cell count can influence water diffusion and ADC. It is well known that other histological factors, such as cell size and nucleic-cytoplasma ratio play a role in restriction of water diffusion [1], [2], [3]. According Matsumoto et al., increase of cell size decreased water diffusion in vitro [18]. Furthermore, it has been shown that nucleic size also affected water diffusion in cell culture [19].

The proposed formula does not consider the fact that several tumors and tumor-like lesions have different cell and nucleic sizes. Therefore, it cannot be used for all tumors. However, our study showed that it provides results, which are concordant with the estimated cell count for HNSCC, cerebral lymphoma and rectal cancer. Clearly, further investigations with different tumors are needed to proof the usefulness of the formula in other malignancies. We hypothesize that in future, more sensitive ADC-based mathematical models adjusted for every tumor entity may better reflect cellularity than a general formula. Furthermore, these models may include other ADC parameters than ADCmean and/or ADCmin. Recently, some reports showed that histogram analysis of ADC maps provided other parameters, which better correlated with tumor cell count [19], [20].

The present study has several limitations. Firstly, it is retrospective. Secondly, the analyzed tumor groups had small number of patients.

In conclusion, our results suggested that the proposed formula for cellularity calculation does not apply for all tumors. It may be used for HNSCC, cerebral lymphomas and rectal cancer, but not for uterine cervical cancer, meningioma, and thyroid cancer. Furthermore, its usefulness should be checked for other tumors.

References

  • 1.Fornasa F. Diffusion-weighted magnetic resonance imaging: what makes water run fast or slow? J Clin Imaging Sci. 2011;1:27. doi: 10.4103/2156-7514.81294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Le Bihan D. Molecular diffusion, tissue microdynamics and microstructure. NMR Biomed. 1995;8:375–386. doi: 10.1002/nbm.1940080711. [DOI] [PubMed] [Google Scholar]
  • 3.Galons JP, Lope-Piedrafita S, Divijak JL, Corum C, Gillies RJ, Trouard TP. Uncovering of intracellular water in cultured cells. Magn Reson Med. 2005;54:79–86. doi: 10.1002/mrm.20565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Harkins KD, Galons JP, Secomb TW, Trouard TP. Assessment of the effects of cellular tissue properties on ADC measurements by numerical simulation of water diffusion. Magn Reson Med. 2009;62:1414–1422. doi: 10.1002/mrm.22155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Matoba M, Tonami H, Kondou T, Yokota H, Higashi K, Toga H, Sakuma T. Lung carcinoma: diffusion-weighted MR imaging-preliminary evaluation with apparent diffusion coefficient. Radiology. 2007;243:570–577. doi: 10.1148/radiol.2432060131. [DOI] [PubMed] [Google Scholar]
  • 6.Surov A, Caysa H, Wienke A, Spielmann RP, Fiedler E. Correlation between different ADC fractions, cell count, Ki-67, total nucleic areas and average nucleic areas in meningothelial meningiomas. Anticancer Res. 2015;35(12):6841–6846. [PubMed] [Google Scholar]
  • 7.Schnapauff D, Zeile M, Niederhagen MB, Fleige B, Tunn PU, Hamm B, Dudeck O. Diffusion-weighted echo-planar magnetic resonance imaging for the assessment of tumor cellularity in patients with soft-tissue sarcomas. J Magn Reson Imaging. 2009;29:1355–1359. doi: 10.1002/jmri.21755. [DOI] [PubMed] [Google Scholar]
  • 8.Atuegwu NC, Arlinghaus LR, Li X, Chakravarthy B, Abramson VG, Sanders ME, Yankeelov TE. Parameterizing the logistic model of tumor growth by DW-MRI and DCE-MRI data to predict treatment response and changes in breast cancer cellularity during neoadjuvant chemotherapy. Transl Oncol. 2013;6:256–264. doi: 10.1593/tlo.13130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Surov A, Gottschling S, Mawrin C, Prell J, Spielmann RP, Wienke A, Fiedler E. Diffusion-weighted imaging in meningioma: prediction of tumor grade and association with histopathological parameters. Transl Oncol. 2015;8:517–523. doi: 10.1016/j.tranon.2015.11.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Surov A, Meyer HJ, Schob S, Höhn AK, Bremicker K, Exner M, Stumpp P, Purz S. Parameters of simultaneous 18F-FDG-PET/MRI predict tumor stage and several histopathological features in uterine cervical cancer. Oncotarget. 2017;8(17):28285–28296. doi: 10.18632/oncotarget.16043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Surov A, Stumpp P, Meyer HJ, Gawlitza M, Hoehn AK, Boehm A, Sabri O, Kahn T, Purz S. Simultaneous 18F-FDG-PET/MRI: Associations between diffusion, glucose metabolism and histopathological parameters in patients with head and neck squamous cell carcinoma. Oral Oncol. 2016;58:14–20. doi: 10.1016/j.oraloncology.2016.04.009. [DOI] [PubMed] [Google Scholar]
  • 12.Surov A, Meyer HJ, Höhn AK, Behrmann C, Wienke A, Spielmann RP, Garnov N. Correlations between intravoxel incoherent motion (IVIM) parameters and histological findings in rectal cancer: preliminary results. Oncotarget. 2017;8(13):21974–22198. doi: 10.18632/oncotarget.15753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Schob S, Voigt P, Bure L, Meyer J, Wickenhauser C, Behrmann C, Höhn AK, Dralle H, Surov A. Diffusion-weighted imaging using a readout-segmented, multi shot EPI sequence at 3T distinguishes between morphologically differentiated and undifferentiated subtypes of thyroid carcinoma- a preliminary study. Transl Oncol. 2016;9(5):403–410. doi: 10.1016/j.tranon.2016.09.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Schob S, Meyer HJ, Gawlitza M, Frydrychowitz C, Müller W, Preuss M, Bure L, Quäschling U, Hoffmann KT, Surov A. Diffusion-weighted imaging reflects proliferative activity in primary CNS lymphoma. PLoS One. 2016;11(8):e0161386. doi: 10.1371/journal.pone.0161386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Yankeelov TE, Atuegwu NC, Deane NG, Gore JC. Modeling tumor growth and treatment response based on quantitative imaging data. Integr Biol. 2010;2:338. doi: 10.1039/b921497f. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Surov A, Meyer HJ, Wienke A. Correlation between apparent diffusion coefficient (ADC) and cellularity is different in several tumors: a meta-analysis. Oncotarget. 2017 doi: 10.18632/oncotarget.17752. [in press] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Surov A, Meyer HJ, Wienke A. Correlation between minimum apparent diffusion coefficient (ADCmin) and tumor cellularity: a meta-analysis. Anticancer Res. 2017 doi: 10.21873/anticanres.11758. [in press] [DOI] [PubMed] [Google Scholar]
  • 18.Matsumoto Y, Kuroda M, Matsuya R, Kato H, Shibuya K, Oita M, Kawabe A, Matsuzaki H, Asaumi J, Murakami J. In vitro experimental study of the relationship between the apparent diffusion coefficient and changes in cellularity and cell morphology. Oncol Rep. 2009;22:641–648. doi: 10.3892/or_00000484. [DOI] [PubMed] [Google Scholar]
  • 19.Xu J, Does MD, Gore JC. Sensitivity of MR diffusion measurements to variations in intracellular structure: effects of nuclear size. Magn Reson Med. 2009;61:828–833. doi: 10.1002/mrm.21793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Schob S, Meyer HJ, Dieckow J, Pervinder B, Pazaitis N, Höhn AK, Garnov N, Horvath-Rizea D, Hoffmann KT, Surov A. Histogram analysis of diffusion weighted imaging at 3T is useful for prediction of lymphatic metastatic spread, proliferative activity, and cellularity in thyroid cancer. Int J Mol Sci. 2017;18(4) doi: 10.3390/ijms18040821. [pii: E821] [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Translational Oncology are provided here courtesy of Neoplasia Press

RESOURCES